These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8218231

  • 1. The allosteric transition of the insulin hexamer is modulated by homotropic and heterotropic interactions.
    Choi WE, Brader ML, Aguilar V, Kaarsholm NC, Dunn MF.
    Biochemistry; 1993 Nov 02; 32(43):11638-45. PubMed ID: 8218231
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the R-state insulin hexamer and its derivatives. The hexamer is stabilized by heterotropic ligand binding interactions.
    Brader ML, Kaarsholm NC, Lee RW, Dunn MF.
    Biochemistry; 1991 Jul 09; 30(27):6636-45. PubMed ID: 2065051
    [Abstract] [Full Text] [Related]

  • 3. Spectroscopic evidence for an intermediate in the T6 to R6 allosteric transition of the Co(II)-substituted insulin hexamer.
    Gross L, Dunn MF.
    Biochemistry; 1992 Feb 11; 31(5):1295-301. PubMed ID: 1736988
    [Abstract] [Full Text] [Related]

  • 4. Structural asymmetry and half-site reactivity in the T to R allosteric transition of the insulin hexamer.
    Brzović PS, Choi WE, Borchardt D, Kaarsholm NC, Dunn MF.
    Biochemistry; 1994 Nov 08; 33(44):13057-69. PubMed ID: 7947711
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of stabilization of the insulin hexamer through allosteric ligand interactions.
    Rahuel-Clermont S, French CA, Kaarsholm NC, Dunn MF, Chou CI.
    Biochemistry; 1997 May 13; 36(19):5837-45. PubMed ID: 9153424
    [Abstract] [Full Text] [Related]

  • 6. Spectroscopic evidence for preexisting T- and R-state insulin hexamer conformations.
    Choi WE, Borchardt D, Kaarsholm NC, Brzovic PS, Dunn MF.
    Proteins; 1996 Dec 13; 26(4):377-90. PubMed ID: 8990494
    [Abstract] [Full Text] [Related]

  • 7. The T to R transition in the copper(II)-substituted insulin hexamer. Anion complexes of the R-state species exhibiting type 1 and type 2 spectral characteristics.
    Brader ML, Borchardt D, Dunn MF.
    Biochemistry; 1992 May 19; 31(19):4691-6. PubMed ID: 1316158
    [Abstract] [Full Text] [Related]

  • 8. Carboxylate ions are strong allosteric ligands for the HisB10 sites of the R-state insulin hexamer.
    Huang ST, Choi WE, Bloom C, Leuenberger M, Dunn MF.
    Biochemistry; 1997 Aug 12; 36(32):9878-88. PubMed ID: 9245420
    [Abstract] [Full Text] [Related]

  • 9. Ligand binding and thermostability of different allosteric states of the insulin zinc-hexamer.
    Huus K, Havelund S, Olsen HB, Sigurskjold BW, van de Weert M, Frokjaer S.
    Biochemistry; 2006 Mar 28; 45(12):4014-24. PubMed ID: 16548529
    [Abstract] [Full Text] [Related]

  • 10. Role of metal ions in the T- to R-allosteric transition in the insulin hexamer.
    Kadima W.
    Biochemistry; 1999 Oct 12; 38(41):13443-52. PubMed ID: 10521251
    [Abstract] [Full Text] [Related]

  • 11. Insulin allosteric behavior: detection, identification, and quantification of allosteric states via 19F NMR.
    Bonaccio M, Ghaderi N, Borchardt D, Dunn MF.
    Biochemistry; 2005 May 31; 44(21):7656-68. PubMed ID: 15909980
    [Abstract] [Full Text] [Related]

  • 12. Structural signatures of the complex formed between 3-nitro-4-hydroxybenzoate and the Zn(II)-substituted R(6) insulin hexamer.
    Olsen HB, Leuenberger-Fisher MR, Kadima W, Borchardt D, Kaarsholm NC, Dunn MF.
    Protein Sci; 2003 Sep 31; 12(9):1902-13. PubMed ID: 12930990
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the allosteric properties of the Co(II)- and Zn(II)-substituted insulin hexamers.
    Bloom CR, Wu N, Dunn A, Kaarsholm NC, Dunn MF.
    Biochemistry; 1998 Aug 04; 37(31):10937-44. PubMed ID: 9692986
    [Abstract] [Full Text] [Related]

  • 14. Ligand perturbation effects on a pseudotetrahedral Co(II)(His)3-ligand site. A magnetic circular dichroism study of the Co(II)-substituted insulin hexamer.
    Brader ML, Kaarsholm NC, Harnung SE, Dunn MF.
    J Biol Chem; 1997 Jan 10; 272(2):1088-94. PubMed ID: 8995407
    [Abstract] [Full Text] [Related]

  • 15. Hierarchical modeling of phenolic ligand binding to 2Zn--insulin hexamers.
    Birnbaum DT, Dodd SW, Saxberg BE, Varshavsky AD, Beals JM.
    Biochemistry; 1996 Apr 30; 35(17):5366-78. PubMed ID: 8611526
    [Abstract] [Full Text] [Related]

  • 16. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review.
    Dunn MF.
    Biometals; 2005 Aug 30; 18(4):295-303. PubMed ID: 16158220
    [Abstract] [Full Text] [Related]

  • 17. Half-site reactivity, negative cooperativity, and positive cooperativity: quantitative considerations of a plausible model.
    Bloom CR, Kaarsholm NC, Ha J, Dunn MF.
    Biochemistry; 1997 Oct 21; 36(42):12759-65. PubMed ID: 9335532
    [Abstract] [Full Text] [Related]

  • 18. Raman signatures of ligand binding and allosteric conformation change in hexameric insulin.
    Ferrari D, Diers JR, Bocian DF, Kaarsholm NC, Dunn MF.
    Biopolymers; 2001 Oct 21; 62(5):249-60. PubMed ID: 11745120
    [Abstract] [Full Text] [Related]

  • 19. Structural transition in the metal-free hexamer of protein-engineered [B13 Gln]insulin.
    Wollmer A, Rannefeld B, Stahl J, Melberg SG.
    Biol Chem Hoppe Seyler; 1989 Sep 21; 370(9):1045-53. PubMed ID: 2692616
    [Abstract] [Full Text] [Related]

  • 20. Analysis of insulin allostery in solution and solid state with FTIR.
    Maltesen MJ, Bjerregaard S, Hovgaard L, Havelund S, van de Weert M.
    J Pharm Sci; 2009 Sep 21; 98(9):3265-77. PubMed ID: 19340886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.